Oracle (NYSE: ORCL) selects Stephen Rusckowski as a director, the board now has a total of 14 members

AUSTIN, Texas, November 20, 2025 /PRNewswire/ – Oracle Corporation (NYSE: ORCL) announced today that it has unanimously elected Stephen Rusckowski to Oracle’s board of directors, increasing the size of the board to 14. The election takes effect on November 18, 2025.

Mr. Rusckowski is the former Chief Executive Officer and President of Quest Diagnostics, Inc. (Quest), a leading provider of diagnostic information, a position he held from 2012 to 2022. He also served as CEO of Quest from January 2017 to March 2023. Prior to joining Quest, he was Chief Executive Officer of Philips Healthcare and a member of the Board of Directors of Royal Philips Electronics. Mr. Rusckowski is currently a member of the Board of Directors of Qiagen NV and a director of Baxter International Inc. Mr. Rusckowski received a Bachelor of Science in Mechanical Engineering from Worcester Polytechnic Institute and a Master of Science in Management from…